Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Assets Average (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Assets Average for 15 consecutive years, with $7.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 53.87% year-over-year to $7.1 million, compared with a TTM value of $7.1 million through Sep 2025, down 53.87%, and an annual FY2024 reading of $12.4 million, down 14.3% over the prior year.
  • Assets Average was $7.1 million for Q3 2025 at BioRestorative Therapies, down from $9.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $21.7 million in Q1 2022 and bottomed at $2.5 million in Q3 2021.
  • Average Assets Average over 5 years is $12.9 million, with a median of $13.6 million recorded in 2023.
  • The sharpest move saw Assets Average soared 638.39% in 2022, then crashed 53.87% in 2025.
  • Year by year, Assets Average stood at $12.3 million in 2021, then skyrocketed by 39.49% to $17.2 million in 2022, then fell by 23.12% to $13.2 million in 2023, then increased by 1.67% to $13.4 million in 2024, then tumbled by 47.27% to $7.1 million in 2025.
  • Business Quant data shows Assets Average for BRTX at $7.1 million in Q3 2025, $9.4 million in Q2 2025, and $11.3 million in Q1 2025.